Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

Clinical trial NCT01499069 · COMPLETED

Trial details

NCT number: NCT01499069
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2010-02-01
Primary completion: 2015-11-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.